Cargando…
SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers
BACKGROUND: The gold standard to identify SARS-CoV-2 infections is the Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) on rhino-pharyngeal swabs, but faster and cheaper methods such as antigenic swabs have been developed. A retrospective observational study on antigenic swabs included in th...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885 srl
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759044/ https://www.ncbi.nlm.nih.gov/pubmed/34939621 http://dx.doi.org/10.23749/mdl.v112i6.12125 |
_version_ | 1784633028481384448 |
---|---|
author | Coggiola, Maurizio Cavallo, Rossana Grillo, Eugenio Frammartino, Roberto Clemente, Giuseppe Costa, Cristina Raciti, Ida Marina Silvestre, Carlo Scozzari, Gitana Paradisi, Ettore Tuffanelli, Alessandro Alfonso Pensamiento, Maria Carolina Godono, Alessandro Pira, Enrico |
author_facet | Coggiola, Maurizio Cavallo, Rossana Grillo, Eugenio Frammartino, Roberto Clemente, Giuseppe Costa, Cristina Raciti, Ida Marina Silvestre, Carlo Scozzari, Gitana Paradisi, Ettore Tuffanelli, Alessandro Alfonso Pensamiento, Maria Carolina Godono, Alessandro Pira, Enrico |
author_sort | Coggiola, Maurizio |
collection | PubMed |
description | BACKGROUND: The gold standard to identify SARS-CoV-2 infections is the Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) on rhino-pharyngeal swabs, but faster and cheaper methods such as antigenic swabs have been developed. A retrospective observational study on antigenic swabs included in the extraordinary health surveillance protocol of a large Hospital in Turin was aimed to assess their performance validity. METHODS: From 30 October 2020 to 4 May 2021, 4000 antigenic swabs were carried out in three groups of healthcare workers (HCWs), respectively (i) asymptomatic, (ii) cohabiting with a positive case, and (iii) not recently exposed to the virus. RESULTS: Overall sensitivity and specificity associated with a prevalence of 1.30% were 26.9%, 97.2%, respectively, the corresponding positive (PPV) and negative predictive value (NPV) being 11.29% and 99.02% [95% IC (99.00 - 99.04)] respectively; a prevalence of 0.29% was observed in the asymptomatic group, among whom sensitivity and specificity were 25.0% and 98.9%, respectively, the corresponding PPV and NPV being 6.25% and 99.78% [95% IC (99.76 - 99.81)], respectively; the cohabitant group showed a prevalence of 21.11%, sensitivity and specificity were 47.4%, 81.7%, respectively, giving rise to a PPV of 40.91% and NPV of 85.29% [95% IC (85.18 – 85.41)] respectively. The prevalence in the not exposed group was 0.77%, sensitivity and specificity were 29.2%, 97.4%, respectively, and PPV and NPV 8.05% and 99.44% [95% IC (99.42 - 99.46)] respectively. CONCLUSIONS: Antigenic swabs reduced costs and provided reliable diagnostic results. In the cohabitant group, the higher-prevalence groups showed poor test performances, likely because of the high prevalence of pre-symptomatic illness in this group. Owing to the relatively low NPV, a negative result would still require confirmation with a molecular test to be acceptable for a surveillance program that effectively reduces the virus’s intra-hospital spread. |
format | Online Article Text |
id | pubmed-8759044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Mattioli 1885 srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-87590442022-01-26 SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers Coggiola, Maurizio Cavallo, Rossana Grillo, Eugenio Frammartino, Roberto Clemente, Giuseppe Costa, Cristina Raciti, Ida Marina Silvestre, Carlo Scozzari, Gitana Paradisi, Ettore Tuffanelli, Alessandro Alfonso Pensamiento, Maria Carolina Godono, Alessandro Pira, Enrico Med Lav Original Article BACKGROUND: The gold standard to identify SARS-CoV-2 infections is the Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) on rhino-pharyngeal swabs, but faster and cheaper methods such as antigenic swabs have been developed. A retrospective observational study on antigenic swabs included in the extraordinary health surveillance protocol of a large Hospital in Turin was aimed to assess their performance validity. METHODS: From 30 October 2020 to 4 May 2021, 4000 antigenic swabs were carried out in three groups of healthcare workers (HCWs), respectively (i) asymptomatic, (ii) cohabiting with a positive case, and (iii) not recently exposed to the virus. RESULTS: Overall sensitivity and specificity associated with a prevalence of 1.30% were 26.9%, 97.2%, respectively, the corresponding positive (PPV) and negative predictive value (NPV) being 11.29% and 99.02% [95% IC (99.00 - 99.04)] respectively; a prevalence of 0.29% was observed in the asymptomatic group, among whom sensitivity and specificity were 25.0% and 98.9%, respectively, the corresponding PPV and NPV being 6.25% and 99.78% [95% IC (99.76 - 99.81)], respectively; the cohabitant group showed a prevalence of 21.11%, sensitivity and specificity were 47.4%, 81.7%, respectively, giving rise to a PPV of 40.91% and NPV of 85.29% [95% IC (85.18 – 85.41)] respectively. The prevalence in the not exposed group was 0.77%, sensitivity and specificity were 29.2%, 97.4%, respectively, and PPV and NPV 8.05% and 99.44% [95% IC (99.42 - 99.46)] respectively. CONCLUSIONS: Antigenic swabs reduced costs and provided reliable diagnostic results. In the cohabitant group, the higher-prevalence groups showed poor test performances, likely because of the high prevalence of pre-symptomatic illness in this group. Owing to the relatively low NPV, a negative result would still require confirmation with a molecular test to be acceptable for a surveillance program that effectively reduces the virus’s intra-hospital spread. Mattioli 1885 srl 2021 2021-12-23 /pmc/articles/PMC8759044/ /pubmed/34939621 http://dx.doi.org/10.23749/mdl.v112i6.12125 Text en Copyright: © 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Original Article Coggiola, Maurizio Cavallo, Rossana Grillo, Eugenio Frammartino, Roberto Clemente, Giuseppe Costa, Cristina Raciti, Ida Marina Silvestre, Carlo Scozzari, Gitana Paradisi, Ettore Tuffanelli, Alessandro Alfonso Pensamiento, Maria Carolina Godono, Alessandro Pira, Enrico SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers |
title | SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers |
title_full | SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers |
title_fullStr | SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers |
title_full_unstemmed | SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers |
title_short | SARS-CoV-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers |
title_sort | sars-cov-2 infection: use and effectiveness of antigenic swab for the health surveillance of healthcare workers |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759044/ https://www.ncbi.nlm.nih.gov/pubmed/34939621 http://dx.doi.org/10.23749/mdl.v112i6.12125 |
work_keys_str_mv | AT coggiolamaurizio sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT cavallorossana sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT grilloeugenio sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT frammartinoroberto sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT clementegiuseppe sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT costacristina sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT racitiidamarina sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT silvestrecarlo sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT scozzarigitana sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT paradisiettore sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT tuffanellialessandro sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT alfonsopensamientomariacarolina sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT godonoalessandro sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers AT piraenrico sarscov2infectionuseandeffectivenessofantigenicswabforthehealthsurveillanceofhealthcareworkers |